Compare FET & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FET | TNDM |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 953.8M | 1.1B |
| IPO Year | 2007 | 2013 |
| Metric | FET | TNDM |
|---|---|---|
| Price | $69.24 | $17.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 25 |
| Target Price | N/A | ★ $27.10 |
| AVG Volume (30 Days) | 138.6K | ★ 2.6M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.64 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | $791,474,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | $15.23 | $6.13 |
| Revenue Next Year | $7.08 | $7.40 |
| P/E Ratio | $30.27 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $29.77 | $12.26 |
| 52 Week High | $91.99 | $29.65 |
| Indicator | FET | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 37.63 | 46.85 |
| Support Level | $67.50 | $14.79 |
| Resistance Level | $85.27 | $17.59 |
| Average True Range (ATR) | 4.04 | 1.52 |
| MACD | -0.48 | -0.21 |
| Stochastic Oscillator | 11.82 | 36.59 |
Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.